Home
/
Envoy Medical, Inc.
/
Financials
/
Quarterly
Envoy Medical, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Envoy Medical, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$42.0K
Nov 10, 2025
Q2
2025
Jun 30, 2025
$78.0K
Jul 31, 2025
Q1
2025
Mar 31, 2025
$46.0K
May 1, 2025
Q3
2025
Sep 30, 2024
$56.0K
Nov 10, 2025
Q2
2025
Jun 30, 2024
$68.0K
Jul 31, 2025
Q1
2025
Mar 31, 2024
$59.0K
May 1, 2025
Q3
2024
Sep 30, 2023
$80.0K
Nov 14, 2024
Q2
2024
Jun 30, 2023
$63.0K
Aug 12, 2024
Q1
2024
Mar 31, 2023
$78.0K
May 15, 2024
Q3
2023
Sep 30, 2022
$57.0K
Jan 17, 2024
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($6.48M)
Nov 10, 2025
Q2
2025
Jun 30, 2025
($5.69M)
Jul 31, 2025
Q3
2025
Jun 30, 2025
($5.69M)
Nov 10, 2025
Q3
2025
Mar 31, 2025
($5.00M)
Nov 10, 2025
Q1
2025
Mar 31, 2025
($5.00M)
May 1, 2025
Q2
2025
Mar 31, 2025
($5.00M)
Jul 31, 2025
Q3
2025
Sep 30, 2024
($5.96M)
Nov 10, 2025
Q2
2025
Jun 30, 2024
($3.95M)
Jul 31, 2025
Q3
2025
Jun 30, 2024
($3.95M)
Nov 10, 2025
Q2
2025
Mar 31, 2024
($6.27M)
Jul 31, 2025
Q3
2025
Mar 31, 2024
($6.27M)
Nov 10, 2025
Q1
2025
Mar 31, 2024
($6.27M)
May 1, 2025
Q3
2024
Sep 30, 2023
$1.56M
Nov 14, 2024
Q2
2024
Jun 30, 2023
($13.25M)
Aug 12, 2024
Q3
2024
Jun 30, 2023
($13.34M)
Nov 14, 2024
Q1
2024
Mar 31, 2023
($13.25M)
May 15, 2024
Q3
2024
Mar 31, 2023
($13.25M)
Nov 14, 2024
Q2
2024
Mar 31, 2023
($13.25M)
Aug 12, 2024
Q3
2023
Sep 30, 2022
($1.34M)
Jan 17, 2024
Q3
2023
Jun 30, 2022
($1.24M)
Jan 17, 2024
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($5.71M)
Nov 10, 2025
Q2
2025
Jun 30, 2025
($5.07M)
Jul 31, 2025
Q1
2025
Mar 31, 2025
($5.11M)
May 1, 2025
Q3
2025
Sep 30, 2024
($4.97M)
Nov 10, 2025
Q2
2025
Jun 30, 2024
($4.85M)
Jul 31, 2025
Q1
2025
Mar 31, 2024
($4.88M)
May 1, 2025
Q3
2024
Sep 30, 2023
($3.39M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($4.48M)
Aug 12, 2024
Q1
2024
Mar 31, 2023
($3.77M)
May 15, 2024
Q3
2023
Sep 30, 2022
($1.80M)
Jan 17, 2024
Q2
2023
Jun 30, 2022
($901.4K)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($1.49M)
May 15, 2023
Q3
2022
Sep 30, 2021
($2.99M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($1.07M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($966.3K)
May 16, 2022